Re-expression of wild-type RASSF1A in ACC cells was able to revert malignant features, highlighting the critical role of cytoskeletal integrity in restraining tumour progression [29] (Figure 1 and Figure 3) (Table 1). This evidence concerns the gene RASSF1 and adrenal cortex carcinoma.